We are a marginally capitalised biotech on the verge of being diluted into oblivion by an opportunistic Chinese Engineer with no medical background. He's about to essentially own our Nobel prize researched respiratory assets in return for Invion gaining the exclusive licence in Aust and NZ for his controversial NGPDT. I hope that the 5% turnover in our share register last week wasn't simply bargain hunting, but the beginning of a last ditch opportunity to buy quality Phase 2 respiratory assets before the company is taken over by Cho.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
0.003(3.19%) |
Mkt cap ! $8.232M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $3.425K | 34.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5200 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 244080 | 3 |
View Market Depth
| Last trade - 15.55pm 25/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |